Currently, samples are only available to Ohio University researchers and their associates. In the future, these samples will be available to all approved researchers. Please check back to this website for updated information as that becomes available.

Any investigators requesting access to specimens from the Biorepository is required to:

  1. Submit a formal proposal to the OU Biorepository Advisory Board.
  2. Submit a formal proposal to the Ohio University Institutional Review Board (IRB) for approval.
  3. Submit a formal proposal to the University Medical associates (UMA) Research Committee for final approval.
    4.

Upon obtaining all approvals, the investigators will be required to sign a Limited Data Set Agreement and complete the OU HIPAA training program. The Limited Data Set Agreement will stipulate what summary clinical information will be provided from the Ohio University Diabetes/Endocrine Diseases Database and will set a time limit on their access to this data set and specimens from the Biorepository. Only the Biorepository Coordinator or a designee will have direct access to the database and be allowed to mine this database to create a list of potential research samples. The requested specimens are retrieved from the Biorepository freezers and provided to the investigators at that time with necessary encrypted, summary clinical information.

We ask that investigators acknowledge the contributions made by the Ohio University Diabetes/Endocrine Diseases Biorepository in all publications and presentations resulting from the use of these samples. Recommended wording be as follows: "samples for this project were provided by the Ohio University Diabetes/Endocrine Diseases Biorepository."

DIABETES / ENDOCRINE
QUICK LINKS
DATABASES
INVENTORY
ACCESS TO INVENTORY
PARTICIPATING PARTNERS
RESEARCH
RELATED LINKS
STAFF
DIABETES / ENDOCRINE HOME
   
 
   
The Ohio University Diabetes/Endocrine Diseases Biorepository is dedicated to not only advancing research in the field of diabetes and other endocrine-related diseases, but also to the protection of those individual persons who have contributed specimens to its cause. Patient privacy and confidentiality of personal health information is of utmost importance to Ohio University and to the Biorepository. The personal health information that accompanies each specimen is encrypted and all personal identifiers removed to insure patient privacy. All specimen containers are bar coded before being placed in storage and contain no personal identifiers. Our procedures strictly adhere to the guidelines set forth by the Health Insurance Portability and Accountability Act (HIPAA) of 1996 and our technicians are HIPAA certified. Research intent and protocols must be approved by the university’s Internal Review Board, the Biorepository Advisory Board, and UMA before any of our stored samples are retrieved for a specific research project. Only research directly related to diabetes, its associated complications, or other endocrine diseases will be granted access to these samples.  
   
   
  Diabetes / Endocrine Diseases Biorepository
Ohio University
101 Konneker Research Labs,
The Ridges, Athens, Ohio 45701
740-597-2114
contact: Jean Thuma
 
Last updated: 03/22/2007